Altimmune Story

<div class='circular--portrait' style='background:#FF0000;color: #F5FFFA;font-size:4em;'>AL</div>
ALT -- USA Stock  

USD 13.78  0.34  2.41%

Altimmune is generating 3.1337% of daily returns assuming volatility of 10.703% on return distribution over 60 days investment horizon. While some of us are excited about ishares space, it makes sense to review Altimmune in greater detail to make a better estimate of its risk and reward. We will go over a few points Altimmune private investors should remember regarding its volatility.
Published over a month ago
View all stories for Altimmune | View All Stories
Altimmune (NASDAQ:ALT) high volatility trend continues
This firm has 1.68 M in debt with debt to equity (D/E) ratio of 0.04, which may show that Altimmune is not taking advantage of profits from borrowing. The company has a current ratio of 6.43, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Altimmune holds a performance score of 20 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -1.0734, which signifies a somewhat significant risk relative to the market. Let's try to break down what Altimmune's beta means in this case. As the market becomes more bullish, returns on owning Altimmune are expected to decrease slowly. On the other hand, during market turmoil, Altimmune is expected to outperform it slightly. Although it is essential to pay attention to Altimmune historical returns, it is also good to be reasonable about what you can do with equity current trending patterns. Our philosophy towards foreseeing future potential of any stock is to look not only at its past charts but also at the business as a whole, including all available fundamental and technical indicators. To evaluate if Altimmune expected return of 3.13 will be sustainable into the future, we have found twenty-one different technical indicators, which can help you to check if the expected returns are sustainable. Use Altimmune variance, value at risk, as well as the relationship between the Value At Risk and skewness to analyze future returns on Altimmune.
Volatility is a rate at which the price of Altimmune or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Altimmune may increase or decrease. In other words, similar to Altimmune's beta indicator, it measures the risk of Altimmune and helps estimate the fluctuations that may happen in a short period of time. So if prices of Altimmune fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.

How important is Altimmune's Liquidity

Altimmune financial leverage refers to using borrowed capital as a funding source to finance Altimmune ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Altimmune financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Altimmune's total debt and its cash.

How Altimmune utilizes its cash?

To perform a cash flow analysis of Altimmune, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Altimmune is receiving and how much cash it distributes out in a given period. The Altimmune cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Altimmune Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Altimmune reported Net Cash Flow from Operations of (9.6 Million) in 2019

Altimmune Volatility Drivers

Altimmune unsystematic risk is unique to Altimmune and usually not directly affected by the market or economic environment. An example of unsystematic risk is the possibility of poor earnings or a layoff due to coronavirus. One may mitigate nonsystematic risk by buying different securities in the same industry or by buying in different sectors. For example, if you have a position in Altimmune you can also buy NantKwest. You can also mitigate this risk by investing in the market neutral sector as well as in companies having nothing to do with it. This type of risk is also called diversifiable risk and can be understood from analyzing Altimmune important indicators over time. Here we run a correlation analysis between relevant fundamental ratios over at least ten year period to find a relationship in the way they react to changes in Altimmune income statement and balance sheet. Here are more details about Altimmune volatility.